Login/Sign Up
Ganivian PFS 0.25 mg Injection 0.5 ml
Ganivian PFS 0.25 mg Injection is used to treat infertility in women. It is also indicated for the inhibition of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation. It contains Ganirelix, which works by inhibiting the action of gonadotropin-releasing hormone (GnRH), resulting in the suppression of the LH. It prevents women from ovulating (release of the egg from the ovary) too soon during the stimulation of their ovaries to produce a mature egg.
₹2332.8*
MRP ₹2592
10% off
₹2203.2*
MRP ₹2592
15% CB
₹388.8 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Ganivian PFS 0.25 mg Injection belongs to the group of medicines called antigonadotropin-releasing hormones used to treat infertility in women. It is indicated for the inhibition of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation.
Ganivian PFS 0.25 mg Injection contains Ganirelix, which works by inhibiting the action of gonadotropin-releasing hormone (GnRH), resulting in the suppression of the LH. It prevents women from ovulating too soon during the stimulation of their ovaries to produce a mature egg.
In some cases, Ganivian PFS 0.25 mg Injection may cause side effects such as injection site reactions, nausea, and headache. Most of these side effects may not require medical attention and resolve gradually over time. However, you are advised to talk to the doctor if the side effects persist or worsen.
Let the doctor know if you are allergic to any components in Ganivian PFS 0.25 mg Injection . Do not use Ganivian PFS 0.25 mg Injection if you are pregnant or breastfeeding. There is no relevant use of Ganivian PFS 0.25 mg Injection in children. Keep your doctor informed about your health condition and medicines to rule out any side effects.
Ganivian PFS 0.25 mg Injection belongs to the group of medicines called antigonadotropin-releasing hormones used to treat infertility in women. It is indicated for the inhibition of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation. Ganivian PFS 0.25 mg Injection contains Ganirelix, which works by inhibiting the action of gonadotropin-releasing hormone (GnRH), resulting in the suppression of the LH. It prevents women from ovulating (release of the egg from the ovary) too soon during the stimulation of their ovaries to produce a mature egg.
Do not use Ganivian PFS 0.25 mg Injection if you are allergic to any of its components, if you are hypersensitive to gonadotropin-releasing hormone (GnRH) or a GnRH analogue, if you have a moderate or severe kidney or liver disease, or if you are pregnant or breastfeeding. During or following hormonal stimulation of the ovaries, ovarian hyperstimulation syndrome may develop. There may be a slightly increased risk of an ectopic pregnancy (pregnancy outside of the uterus) in women with damaged fallopian tubes. Inform the doctor if you weigh below 50 kg or above 90 kg. Let the doctor know if you are taking any other medicines, including vitamin/mineral supplements or herbal products.
Drug-Drug Interactions: No interactions found/established.
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: No interactions found/established.
Female infertility: It is a condition in which a woman cannot become pregnant even after trying for at least one year or six months if the woman is over 35 years old. Age, hormonal problems, physical problems, lifestyle or environmental factors could be the causes of infertility.
Alcohol
Consult your doctor
It is not known if alcohol affects Ganivian PFS 0.25 mg Injection . Please consult your doctor.
Pregnancy
Unsafe
Do not use Ganivian PFS 0.25 mg Injection if you are pregnant, as it may cause birth defects.
Breast Feeding
Unsafe
Do not use Ganivian PFS 0.25 mg Injection if you are breastfeeding.
Driving
Consult your doctor
The effect of Ganivian PFS 0.25 mg Injection on the ability to drive has not been studied. Drive or operate machinery only if you are alert.
Liver
Caution
Ganivian PFS 0.25 mg Injection is not recommended for use if you have moderate or severe liver disease. Please consult the doctor if you have a liver impairment or any concerns regarding this.
Kidney
Caution
Ganivian PFS 0.25 mg Injection is not recommended for use if you have moderate or severe kidney disease. Please consult the doctor if you have kidney impairment or any concerns regarding this.
Children
Consult your doctor
There is no relevant use of Ganivian PFS 0.25 mg Injection in children or adolescents.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes